Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer

Journal of Clinical Oncology

Volumn 34, Issue 20, 2016, Pages 2366-2371

  Hurria, Arti ^a   Mohile, Supriya ^b   Gajra, Ajeet ^c   Klepin, Heidi ^e   Muss, Hyman ^f   Chapman, Andrew ^h   Feng, Tao ^a   Smith, David ^a   Sun, Can Lan ^a   De Glas, Nienke ⁱ   Cohen, Harvey Jay ^g   Katheria, Vani ^a   Doan, Caroline ^a   Zavala, Laura ^a   Levi, Abrahm ^a   Akiba, Chie ^a   Tew, William P ^d  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g DUKE UNIVERSITY   (United States)

^h THOMAS JEFFERSON UNIVERSITY   (United States)

ⁱ LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; DEATH; DIGESTIVE SYSTEM CANCER; FATIGUE; FEMALE; FEMALE GENITAL TRACT CANCER; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; INFECTION; KARNOFSKY PERFORMANCE STATUS; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK; SCORING SYSTEM; SOLID TUMOR; UROGENITAL TRACT CANCER; GERIATRIC ASSESSMENT; NEOPLASMS; VALIDATION STUDY;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; NEOPLASMS;

EID: 84977491955     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.65.4327     Document Type: Article

References (27)

1. Siegel RL, Miller KD, Jemal A: Cancer statistics, 2015. CA Cancer J Clin 65:5-29, 2015
2. Hurria A, Togawa K, Mohile SG, et al: Predicting chemotherapy toxicity in older adults with cancer: A prospective multicenter study. J Clin Oncol 29:3457-3465, 2011
3. Extermann M, Boler I, Reich RR, et al: Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 118: 3377-3386, 2012
4. Muss HB, Berry DA, Cirrincione C, et al: Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B Experience. J Clin Oncol 25:3699-3704, 2007
5. Hurria A, Wong FL, Villaluna D, et al: Role of age and health in treatment recommendations for older adults with breast cancer: The perspective of oncologists and primary care providers. J Clin Oncol 26:5386-5392, 2008
6. Kornblith AB, Kemeny M, Peterson BL, et al: Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 95:989-996, 2002
7. Macleod CM (ed): The clinical evaluation of chemotherapeutic agents in cancer, in Evaluation of Chemotherapeutic Agents. New York, NY, Columbia University Press, 1948, pp 191-205
8. Zubrod C, Schneiderman M, Frei E: Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 11:7-33, 1960
9. Bajorin DF, Dodd PM, Mazumdar M, et al: Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy. J Clin Oncol 17:3173-3181, 1999
10. Motzer RJ, Bacik J, Schwartz LH, et al: Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 22:454-463, 2004
11. Albain KS, Crowley JJ, Le Blanc M, et al: Survival determinants in extensive-stage non-smallcell lung cancer: The Southwest Oncology Group experience. J Clin Oncol 9:1618-1626, 1991
12. Chiang LY, Liu J, Flood KL, et al: Geriatric assessment as predictors of hospital readmission in older adults with cancer. J Geriatr Oncol 6:254-261, 2015
13. Wildiers H, Heeren P, Puts M, et al: International Society of Geriatric Oncology consensus on geriatric assessment in older patientswith cancer. J Clin Oncol 32:2595-2603, 2014
14. Dale W, Mohile SG, Eldadah BA, et al: Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst 104:581-589, 2012
15. Trotti A, Colevas AD, Setser A, et al: CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176-181, 2003
16. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36, 1982
17. De Long ER, De Long DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44:837-845, 1988
18. Vergouwe Y, Steyerberg EW, Eijkemans MJ, et al: Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol 58: 475-483, 2005
19. Hutchins LF, Unger JM, Crowley JJ, et al: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341: 2061-2067, 1999
20. Zulman DM, Sussman JB, Chen X, et al: Examining the evidence: A systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 26:783-790, 2011
21. Dees EC, O'Reilly S, Goodman SN, et al: A prospective pharmacologic evaluation of age-related toxicity of adjuvant chemotherapy in women with breast cancer. Cancer Invest 18:521-529, 2000
22. Gómez H, Hidalgo M, Casanova L, et al: Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: Results of a multivariate analysis. J Clin Oncol 16:2065-2069, 1998
23. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33:278-285, 1985
24. Hurria A, Wildes T, Blair SL, et al: Senior adult oncology, version 2.2014: Clinical practice guidelines in oncology. J Natl Compr Canc Netw 12:82-126, 2014
25. Hurria A, Cirrincione CT, Muss HB, et al: Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 29:1290-1296, 2011
26. Hamaker ME, Schiphorst AH, ten Bokkel Huinink D, et al: The effect of a geriatric evaluation on treatment decisions for older cancer patients-A systematic review. Acta Oncol 53:289-296, 2014
27. Steyerberg EW, Bleeker SE, Moll HA, et al: Internal and external validation of predictive models: A simulation study of bias and precision in small samples. J Clin Epidemiol 56:441-447, 2003